Sie befinden sich hier: Mitarbeiter > publist

Prof. Dr. med. Michael Weichenthal
Aktuelle Publikationen


2017

Keine Einträge

2016

Maul LV, Weichenthal M, Kahler K, Hauschild A
Pembrolizumab in an advanced melanoma and immune suppressed patient with a churg-strauss syndrome following ipilimumab-induced colitis.
Oncol Res Treat 2016;39:148-149

2015

Koch M, Baurecht H, Ried JS, Rodriguez E, Schlesinger S, Volks N, Gieger C, Rückert IM, Heinrich L, Willenborg C, Smith C, Peters A, Thorand B, Koenig W, Lamina C, Jansen H, Kronenberg F, Seissler J, Thiery J, Rathmann W, Schunkert H, Erdmann J, Barker J, Nair RP, Tsoi LC, Elder JT, Mrowietz U, Weichenthal M, Mucha S, Schreiber S, Franke A, Schmitt J, Lieb W, Weidinger S.
Psoriasis and Cardiometabolic Traits: Modest Association but Distinct Genetic Architectures.
J Invest Dermatol. 2015;135(5):1283-93
Baurecht H, Hotze M, Brand S, Büning C, Cormican P, Corvin A, Ellinghaus D, Ellinghaus E, Esparza-Gordillo J, Fölster-Holst R, Franke A, Gieger C, Hubner N, Illig T, Irvine AD, Kabesch M, Lee YA, Lieb W, Marenholz I, McLean WH, Morris DW, Mrowietz U, Nair R, Nöthen MM, Novak N, O'Regan GM; PAGE Consortium, Schreiber S, Smith C, Strauch K, Stuart PE, Trembath R, Tsoi LC, Weichenthal M, Barker J, Elder JT, Weidinger S, Cordell HJ, Brown SJ
Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms.
Am J Hum Genet. 2015;96(1):104-20
Yin X, Low HQ, Wang L, Li Y, Ellinghaus E, Han J, Estivill X, Sun L, Zuo X, Shen C, Zhu C, Zhang A, Sanchez F, Padyukov L, Catanese JJ, Krueger GG, Duffin KC, Mucha S, Weichenthal M, Weidinger S, Lieb W, Foo JN, Li Y, Sim K, Liany H, Irwan I, Teo Y, Theng CT, Gupta R, Bowcock A, De Jager PL, Qureshi AA, de Bakker PI, Seielstad M, Liao W, Ståhle M, Franke A, Zhang X, Liu J
Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility
Nat Commun 2015;23;6:e6916
Tsoi LC, Spain SL, Ellinghaus E, Stuart PE, Capon F, Knight J, Tejasvi T, Kang HM, Allen MH, Lambert S, Stoll SW, Weidinger S, Gudjonsson JE, Koks S, Kingo K, Esko T, Das S, Metspalu A, Weichenthal M, Enerback C, Krueger GG, Voorhees JJ, Chandran V, Rosen CF, Rahman P, Gladman DD, Reis A, Nair RP, Franke A, Barker JN, Abecasis GR, Trembath RC, Elder JT.
Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci
Nat Commun 2015;5;6:e7001
Wehkamp U, Glaeser D, Oschlies I, Hilgendorf I, Klapper W, Weichenthal M
Successful stem cell transplantation in a patient with primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma
Br J Dermatol 2015;173(3):869-71
Wehkamp U, Pott C, Unterhalt M, Koch K, Weichenthal M, Klapper W, Oschlies I
Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type
Am J Surg Pathol 2015;39(8):1093-101
Wehkamp U, Oschlies I, Nagel I, Brasch J, Kneba M, Günther A, Klapper W, Weichenthal M
ALK-positive primary cutaneous T-cell-lymphoma (CTCL) with unusual clinical presentation and aggressive course
J Cutan Pathol 2015;11:870-7
Calderon C, Zucht HD, Kuhn A, Wozniacka A, Szepietowski JC, Nyberg F, Weichenthal M, Piantone A, Budde P
A multicenter photoprovocation study to identify potential biomarkers by global peptide profiling in cutaneous lupus erythematosus
Lupus 2015;24(13):1406-20
Weichenthal, M
Psoriasis, depression and atrial fibrillation: listen to your heart
British Journal of Dermatology 2015;173: 326-327
Mohr P, Hauschild A, Trefzer U, Enk A, Tilgen W, Loquai C, Gogas H, Haalck T, Koller J, Dummer R, Gutzmer R, Brockmeyer N, Hölzle E, Sunderkötter C, Mauch C, Stein A, Schneider LA, Podda M, Göppner D, Schadendorf D, Weichenthal M.
Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial.
J Clin Oncol. 2015;33(34):4077-84
Stuart PE, Nair RP, Tsoi LC, Tejasvi T, Das S, Kang HM, Ellinghaus E, Chandran V, Callis-Duffin K, Ike R, Li Y, Wen X, Enerbäck C, Gudjonsson JE, Kõks S, Kingo K, Esko T, Mrowietz U, Reis A, Wichmann HE, Gieger C, Hoffmann P, Nöthen MM, Winkelmann J, Kunz M, Moreta EG, Mease PJ, Ritchlin CT, Bowcock AM, Krueger GG, Lim HW, Weidinger S, Weichenthal M, Voorhees JJ, Rahman P, Gregersen PK, Franke A, Gladman DD, Abecasis GR, Elder JT.
Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture.
Am J Hum Genet. 2015;97(6):816-36

2014

Jockenhöfer F, Gollnick H, Herberger K, Isbary G, Renner R, Stücker M, Valesky E, Wollina U, Weichenthal M, Karrer S, Stoffels-Weindorf M, Dissemond J
W.A.R. scores in patients with chronic leg ulcers: results of a multicentre study.
J Wound Care 2014;23(1):5-6
Hauschild A, Chen SC, Weichenthal M, Blum A, King HC, Goldsmith J, Scharfstein D, Gutkowicz-Krusin D
To excise or not: impact of MelaFind on German dermatologists' decisions to biopsy atypical lesions.
J Dtsch Dermatol Ges 2014;12(7):606-14
Okada Y, Han B, Tsoi LC, Stuart PE, Ellinghaus E, Tejasvi T, Chandran V, Pellett F, Pollock R, Bowcock AM, Krueger GG, Weichenthal M, Voorhees JJ, Rahman P, Gregersen PK, Franke A, Nair RP, Abecasis GR, Gladman DD, Elder JT, de Bakker PI, Raychaudhuri S
Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes.
Am J Hum Genet 2014;95(2):162-72
Jockenhöfer F, Gollnick H, Herberger K, Isbary G, Renner R, Stücker M, Valesky E, Wollina U, Weichenthal M, Karrer S, Ross B, Heintschel von Heinegg E, Dissemond J
Current detection rates of multiresistant gram negative bacteria (3MRGN, 4MRGN) in patients with chronic leg ulcers
Hautarzt 2014;65(11):967-73
Jockenhöfer F, Gollnick H, Herberger K, Isbary G, Renner R, Stücker M, Valesky E, Wollina U, Weichenthal M, Karrer S, Kuepper B, Roesch A, Dissemond J
Aetiology, comorbidities and cofactors of chronic leg ulcers: retrospective evaluation of 1?000 patients from 10 specialised dermatological wound care centers in Germany
Int Wound J 2014;[Epub ahead of print]

2013

Volks N, Oschlies I, Cario G, Weichenthal M, Fölster-Holst R.
Primary Cutaneous CD4+ Small to Medium-Size Pleomorphic T-Cell Lymphoma in a 12-Year-Old Girl.
Pediatr Dermatol 2013;30(5):595-9
Degen A, Weichenthal M, Ugurel S, Trefzer U, Kilian K, Garbe C, Egberts F, Poppe LM, Hauschild A, Gutzmer R
Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial)
J Dtsch Dermatol. Ges. 2013;11(9):846-53
Assaf C, Becker JC, Beyer M, Cozzio A, Dippel E, Klemke CD, Kurschat P, Weichenthal M, Stadler R
Treatment of advanced cutaneous T-cell lymphomas with non-pegylated liposomal doxorubicin--consensus of the lymphoma group of the Working Group Dermatologic Oncology.
J Dtsch Dermatol Ges. 2013;11(4):338-47
Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gärtner J, Gutzmer R, Hassel J, Hauschild A, Hohenberger P, Hübner J, Kaatz M, Kleeberg UR, Kölbl O, Kortmann RD, Krause-Bergmann A, Kurschat P, Leiter U, Link H, Loquai C, Löser C, Mackensen A, Meier F, Mohr P, Möhrle M, Nashan D, Reske S, Rose C, Sander C, Satzger I, Schiller M, Schlemmer HP, Strittmatter G, Sunderkötter C, Swoboda L, Trefzer U, Voltz R, Vordermark D, Weichenthal M, Werner A, Wesselmann S, Weyergraf AJ, Wick W, Garbe C, Schadendorf D; German Society of Dermatology.
S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version
J Dtsch Dermatol Ges 2013;11(6):563-602
Stadler R, Assaf C, Klemke CD, Nashan D, Weichenthal M, Dummer R, Sterry W
Brief S2k guidelines--Cutaneous lymphomas.
J Dtsch Dermatol Ges 2013;11 Suppl 3:19-28
Jockenhöfer F, Gollnick H, Herberger K, Isbary G, Renner R, Stücker M, Valesky E, Wollina U, Weichenthal M, Karrer S, Klode J, Dissemond J
Bacteriological pathogen spectrum of chronic leg ulcers: Results of a multicenter trial in dermatologic wound care centers differentiated by regions.
J Dtsch Dermatol Ges. 2013;11(11):1057-63
Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gärtner J, Gutzmer R, Hassel J, Hauschild A, Hohenberger P, Hübner J, Kaatz M, Kleeberg UR, Kölbl O, Kortmann RD, Krause-Bergmann A, Kurschat P, Leiter U, Link H, Loquai C, Löser C, Mackensen A, Meier F, Mohr P, Möhrle M, Nashan D, Reske S, Rose C, Sander C, Satzger I, Schiller M, Schlemmer HP, Strittmatter G, Sunderkötter C, Swoboda L, Trefzer U, Voltz R, Vordermark D, Weichenthal M, Werner A, Wesselmann S, Weyergraf AJ, Wick W, Garbe C, Schadendorf D.
Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
J Dtsch Dermatol Ges. 2013;11 Suppl6:1-116

2012

Gerdes S, Osadtschy S, Rostami-Yazdi M, Buhles N, Weichenthal M, Mrowietz U.
Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?
Exp Dermatol. 2012;21(1):43-7
Jensen JM, Scherer A, Wanke C, Bräutigam M, Bongiovanni S, Letzkus M, Staedtler F, Kehren J, Zuehlsdorf M, Schwarz T, Weichenthal M, Fölster-Holst R, Proksch E
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis
Allergy 2012;67(3):413-23
Westermann L, Hügel R, Meier M, Weichenthal M, Zillikens D, Gläser R, Schmidt E
Glucocorticosteroid-resistant pemphigoid gestationis: successful treatment with adjuvant immunoadsorption
J Dermatol. 2012;39(2):168-71
Jantschitsch C, Weichenthal M, Proksch E, Schwarz T, Schwarz A
IL-12 and IL-23 affect photocarcinogenesis differently.
J Invest Dermatol. 2012;132(5):1479-86
Egberts F, Kotthoff AM, Gerdes S, Egberts JH, Weichenthal M, Hauschild A
Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
Eur J Cancer 2012;48(5): 695-702
Ellinghaus E, Stuart PE, Ellinghaus D, Nair RP, Debrus S, Raelson JV, Belouchi M, Tejasvi T, Li Y, Tsoi LC, Onken AT, Esko T, Metspalu A, Rahman P, Gladman DD, Bowcock AM, Helms C, Krueger GG, Koks S, Kingo K, Gieger C, Wichmann HE, Mrowietz U, Weidinger S, Schreiber S, Abecasis GR, Elder JT, Weichenthal M, Franke A.
Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL.
J Invest Dermatol 2012;132(4):1133-40
Ellinghaus D, Ellinghaus E, Nair RP, Stuart PE, Esko T, Metspalu A, Debrus S, Raelson JV, Tejasvi T, Belouchi M, West SL, Barker JN, Kõks S, Kingo K, Balschun T, Palmieri O, Annese V, Gieger C, Wichmann HE, Kabesch M, Trembath RC, Mathew CG, Abecasis GR, Weidinger S, Nikolaus S, Schreiber S, Elder JT, Weichenthal M, Nothnagel M, Franke A.
Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci.
Am J Hum Genet 2012;90(4):636-47
Dummer R, Quaglino P, Becker JC, Hasan B, Karrasch M, Whittaker S, Morris S, Weichenthal M, Stadler R, Bagot M, Cozzio A, Bernengo MG, Knobler R.
Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012.
J Clin Oncol 2012;30(33): 4091-7
Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, Kang HM, Allen MH, McManus R, Novelli G, Samuelsson L, Schalkwijk J, Ståhle M, Burden AD, Smith CH, Cork MJ, Estivill X, Bowcock AM, Krueger GG, Weger W, Worthington J, Tazi-Ahnini R, Nestle FO, Hayday A, Hoffmann P, Winkelmann J, Wijmenga C, Langford C, Edkins S, Andrews R, Blackburn H, Strange A, Band G, Pearson RD, Vukcevic D, Spencer CC, Deloukas P, Mrowietz U, Schreiber S, Weidinger S, Koks S, Kingo K, Esko T, Metspalu A, Lim HW, Voorhees JJ, Weichenthal M, Wichmann HE, Chandran V, Rosen CF, Rahman P, Gladman DD, Griffiths CE, Reis A, Kere J; Collaborative Association Study of Psoriasis (CASP); Genetic Analysis of Psoriasis Consortium; Psoriasis Association Genetics Extension; Wellcome Trust Case Control Consortium 2, Nair RP, Franke A, Barker JN, Abecasis GR, Elder JT, Trembath RC.
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.
Nat Genet. 2012;44(12):1341-8

2011

Gahr N, Fölster-Holst R, Weichenthal M, Christophers E, Schröder JM, Bartels J
Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to interleukin-4 stimulation
Br J Dermatol 2011;164:586-92
Jensen JM, Scherer A, Wanke C, Bräutigam M, Bongiovanni S, Letzkus M, Staedtler F, Kehren J, Zuehlsdorf M, Schwarz T, Weichenthal M, Fölster-Holst R, Proksch E.
Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis.
Allergy 2011;Epub ahead of print
Jantschitsch C, Weichenthal M, Maeda A, Proksch E, Schwarz T, Schwarz A.
Infrared radiation does not enhance the frequency of ultraviolet radiation-induced skin tumors, but their growth behaviour in mice.
Exp Dermatol 2011;20(4):346-50
Egberts F, Gutzmer R, Ugurel S, Becker JC, Trefzer U, Degen A, Schenck F, Frey L, Wilhelm T, Hassel JC, Schadendorf D, Livingstone E, Mauch C, Garbe C, Berking C, Rass K, Mohr P, Kaehler KC, Weichenthal M, Hauschild A.
Sorafenib and pegylated interferon-?2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial.
Ann Oncol 2011;22(7):1667-74
Hofmann MA, Hauschild A, Mohr P, Garbe C, Weichenthal M, Trefzer U, Drecoll U, Tilgen W, Schadendorf D, Kaatz M, Ulrich J.
Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trial.
Melanoma Res 2011;21(6):516-23

2010

Hauschild A, Weichenthal M, Rass K, Linse R, Berking C, Böttjer J, Vogt T, Spieth K, Eigentler T, Brockmeyer NH, Stein A, Näher H, Schadendorf D, Mohr P, Kaatz M, Tronnier M, Hein R, Schuler G, Egberts F, Garbe C.
Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial.
J Clin Oncol. 2010;28(5):841-6
Egberts F, Momkvist A, Egberts JH, Kaehler KC, Weichenthal M, Hauschild A.
Clinicopathologic prognostic markers of survival: an analysis of 259 patients with malignant melanoma >or=1 mm.
Tumour Biol. 2010;31(1):8-15.
Gahr N, Fölster-Holst R, Weichenthal M, Christophers E, Schröder JM, Bartels J.
Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased Eotaxin/CCL11 responsiveness to IL-4 stimulation.
Br J Dermatol. 2010;doi: 10.1111/j.1365-2133
Gerdes S, Zahl VA, Weichenthal M, Mrowietz U.
Smoking and alcohol intake in severely affected patients with psoriasis in Germany.
Dermatology 2010;220(1):38-43
Stang A, Weichenthal M
Micrographic surgery of skin cancer in German hospitals 2005-2006.
J Eur Acad Dermatol Venerol. 2010;Ahaed of print
Sun LD, Cheng H, Wang ZX, Zhang AP, Wang PG, Xu JH, Zhu QX, Zhou HS, Ellinghaus E, Zhang FR, Pu XM, Yang XQ, Zhang JZ, Xu AE, Wu RN, Xu LM, Peng L, Helms CA, Ren YQ, Zhang C, Zhang SM, Nair RP, Wang HY, Lin GS, Stuart PE, Fan X, Chen G, Tejasvi T, Li P, Zhu J, Li ZM, Ge HM, Weichenthal M, Ye WZ, Zhang C, Shen SK, Yang BQ, Sun YY, Li SS, Lin Y, Jiang JH, Li CT, Chen RX, Cheng J, Jiang X, Zhang P, Song WM, Tang J, Zhang HQ, Sun L, Cui J, Zhang LJ, Tang B, Huang F, Qin Q, Pei XP, Zhou AM, Shao LM, Liu JL, Zhang FY, Du WD, Franke A, Bowcock AM, Elder JT, Liu JJ, Yang S, Zhang XJ
Association analyses identify six new psoriasis susceptibility loci in the Chinese population.
Nat Genet. 2010;42(11):1005-9
Stuart PE, Nair RP, Ellinghaus E, Ding J, Tejasvi T, Gudjonsson JE, Li Y, Weidinger S, Eberlein B, Gieger C, Wichmann HE, Kunz M, Ike R, Krueger GG, Bowcock AM, Mrowietz U, Lim HW, Voorhees JJ, Abecasis GR, Weichenthal M, Franke A, Rahman P, Gladman DD, Elder JT.
Genome-wide association analysis identifies three psoriasis susceptibility loci.
Nat Genet. 2010;42(11):1000-4
Ding J, Gudjonsson JE, Liang L, Stuart PE, Li Y, Chen W, Weichenthal M, Ellinghaus E, Franke A, Cookson W, Nair RP, Elder JT, Abecasis GR.
Gene expression in skin and lymphoblastoid cells: Refined statistical method reveals extensive overlap in cis-eQTL signals.
Am J Hum Genet 2010;87(6):779-89
Ellinghaus E, Ellinghaus D, Stuart PE, Nair RP, Debrus S, Raelson JV, Belouchi M, Fournier H, Reinhard C, Ding J, Li Y, Tejasvi T, Gudjonsson J, Stoll SW, Voorhees JJ, Lambert S, Weidinger S, Eberlein B, Kunz M, Rahman P, Gladman DD, Gieger C, Wichmann HE, Karlsen TH, Mayr G, Albrecht M, Kabelitz D, Mrowietz U, Abecasis GR, Elder JT, Schreiber S, Weichenthal M, Franke A.
Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2.
Nat Genet 2010;42(11):991-995
Weichenthal M
Infektionen durch Korynebakterien
in: Plettenberg A, Meigel, W., Schöfer, H. (ed): Infektionskrankheiten der Haut. 2010;Stuttgart, New York, Georg Thieme Verlag, pp 256-260
Weichenthal M
Sonstige Tumoren
in: Szeimies R, Hauschild A, Garbe C, Kaufmann R, Landthaler M: Tumoren der Haut; Stuttgart, Georg Thieme Verlag 2010;pp 96 - 103

2009

Mohr P, Hauschild A, Trefzer U, Weichenthal M.
Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanoma.
J Clin Oncol. 2009;27(24):e70
Jensen JM, Pfeiffer S, Witt M, Bräutigam M, Neumann C, Weichenthal M, Schwarz T, Fölster-Holst R, Proksch E.
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.
J Allergy Clin Immunol. 2009;124(3 Suppl 2):R19-28
Hauschild A, Weichenthal M, Rass K, Linse R, Ulrich J, Stadler R, Volkenandt M, Grabbe S, Proske U, Schadendorf D, Brockmeyer N, Vogt T, Rompel R, Kaufmann R, Kaatz M, Näher H, Mohr P, Eigentler T, Livingstone E, Garbe C.
Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma.
J Clin Oncol. 2009;27(21):3496-502
Velasco P, Huegel R, Brasch J, Schröder JM, Weichenthal M, Stockfleth E, Schwarz T, Lawler J, Detmar M, Lange-Asschenfeldt B.
The angiogenesis inhibitor thrombospondin-1 inhibits acute cutaneous hypersensitivity reactions.
J Invest Dermatol. 2009;129(8):2022-30
Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, Ruether A, Schreiber S, Weichenthal M, Gladman D, Rahman P, Schrodi SJ, Prahalad S, Guthery SL, Fischer J, Liao W, Kwok PY, Menter A, Lathrop GM, Wise CA, Begovich AB, Voorhees JJ, Elder JT, Krueger GG, Bowcock AM, Abecasis GR; Collaborative Association Study of Psoriasis.
Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.
Nat Genet. 2009;41(2):199-204
Gerdes S, Zahl VA, Weichenthal M, Mrowietz U
Smoking and alcohol intake in severely affected patients with psoriasis in Germany
Dermatology 2009;Dec 9
Egberts F, Hitschler WN, Weichenthal M, Hauschild A
Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse
Melanoma Res. 2009;19(1):31-5

2008

Nair RP, Ruether A, Stuart PE, Jenisch S, Tejasvi T, Hiremagalore R, Schreiber S, Kabelitz D, Lim HW, Voorhees JJ, Christophers E, Elder JT, Weichenthal M,
Polymorphism of the IL12B and IL23R genes are associated with psoriasis.
J Invest Dermatol 2008;128:1653-61
Assaf C, Weichenthal M.
Therapy of cutaneous T-cell lymphoma.
J Dtsch Dermatol Ges 2008;6(3):256-258
Stadler R, Assaf C, Klemke CD, Nashan D, Weichenthal M, Dummer R, Sterry W
Short German guidelines: Cutaneous lymphomas.
J Dtsch Dermatol Ges 2008;6(suppl.1): 25-31
Egberts F, Pollex A, Egberts JH, Kaehler KC, Weichenthal M, Hauschild A.
Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.
Onkologie 2008;31(7):380-4.
Garbe C, Radny P, Linse R, Dummer R, Gutzmer R, Ulrich J, Stadler R, Weichenthal M, Eigentler T, Ellwanger U, Hauschild A
Adjuvant low-dose interferon {alpha}2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis.
Ann Oncol 2008;19(6):1195-201
Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mrowietz U
Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis.
Br J Dermatol 2008;159(5):1116-23

2007

Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M, Glaser R
Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours
J Cancer Res Clin Oncol 2007;133(4):253-61
Weichenthal M, Ruether A, Schreiber S, Nair R, Voorhees JJ, Schwarz T, Kabelitz D, Christophers E, Elder JT, Jenisch S.
Filaggrin R501X and 2282del4 mutations are not associated with chronic plaque-type psoriasis in a German cohort.
J Invest Dermatol. 2007;127(6): 1535-7

2006

Fölster-Holst R, Muller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T, von Ruden U, Schrezenmeir J, Christophers E, Weichenthal M.
Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis.
Br J Dermatol. 2006;155(6):1256-61
Neuber K, Mahnss B, Hubner C, Gergely H, Weichenthal M
Autoantibodies against CD28 are associated with atopic diseases.
Clin Exp Immunol 2006;246:262-269
Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M.
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
Arch Dermatol Res 2006;392:321-328
Brasch J, Weichenthal M, Szliska C, Loffler H, Koch P, Grabbe J, Mahler V, Kreilgard B, Hoeck U; German Contact Dermatitis Research Group
Positive patch test reactions to nickel sulphate are not modified by neighbouring negative fragrance patch tests. A multicenter-study by the German contact dermatitis research group.
Acta Derm Venereol 2006;86:345-347
Dummer R, Hauschild A, Skalsky J, Burg G, Weichenthal M.
Bexarotene and systemic disease progression in CTCL?
J Am Acad Dermatol 2006;55:365-366
Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S, Weichenthal M, Abecasis GR, Lim HW, Christophers E, Voorhees JJ, Elder JT.
Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene.
Am J Hum Genet 2006;78:827-851
Fölster-Holst R, Pape M, Buss YL, Christophers E, Weichenthal M.
Low prevalence of the intrinsic form of atopic dermatitis among adult patients.
Allergy 2006;61:629-632
Jenisch S, Hampe J, Elder JT, Nair R, Stuart P, Voorhees JJ, Schreiber S, Kabelitz D, Christophers E, Weichenthal M.
CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of association.
Arch Dermatol Res 2006;297:409-411
Dummer R, Bonnekoh B, Weichenthal M
Aktuelle Aspekte zur Therapie kutaner T-Zell-Lymphome. Ergebnisse eines TED-basierten interaktiven Symposiums.
Akt Dermatol 2006;32: 432-435
Mrowietz U, Weichenthal M
Erythemato-squamöse Erkrankungen
In: A.Meves (Hg.) Intensivkurs Dermatologie. Urban und Fischer, München, Jena 2006;277-289
Weichenthal M, Schadendorf D, Garbe C
Kosten und Nutzen der Ausbreitungsdiagnostik beim Melanom
In: Claus Garbe (Hg) Management des Melanoms. Springer Medizin Verlag Heidelberg 2006;171-180

2005

Stuart P, Nair RP, Abecasis GR, Nistor I, Hiremagalore R, Chia NV, Qin ZS, Thompson RA, Jenisch S, Weichenthal M, Janiga J, Lim HW, Christophers E, Voorhees JJ, Elder JT
Analysis of RUNX1 Binding Site and RAPTOR Polymorphisms in Psoriasis: No Evidence for Association Despite Adequate Power and Evidence for Linkage
JOURNAL OF MEDICAL GENETICS 2005;42:500-502
Elder JT, Nair RP, Weichenthal M, Stuart P, Voorhees JJ, Christophers E, Jenisch S
The MHC Genes in Psoriasis
Current Genomics 2005;6:39-43
Hoffmann C, Horst HA, Weichenthal M, Hauschild A
Malignant melanoma and HIV infection -- aggressive course despite immune reconstitution
ONKOLOGIE 2005;28:35-37
Elder JT, Abecasis G, Allen M, Barker JNWN, Burden D, Capon F, Christophers E, Fischer J, Giardina E, Gudjonsson JE, Hüffmeier U, Jenisch S, Karason A, Kere J, Nair RP, Sanchez F, Stahle M, Stuart P, Tillman D, Traupe H, Veal C, Voorhees JJ, Weichenthal
Fine Mapping of the Psoriasis Susceptibility Gene PSORS1: A Reassessment of Risk Associated with a Putative Risk Haplotype Lacking HLA-Cw6
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2005;124:921-930
Weichenthal M, Schwarz T
Phototherapy: how does UV work?
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE  2005;21:260-266
Nistor I, Nair RP, Stuart P, Hiremagalore R, Thompson RA, Jenisch S, Weichenthal M, Abecasis GR, Qin ZS, Christophers E, Lim HW, Voorhees JJ, Elder JT
Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association.
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2005;125:395-396
Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H Jr, Fellermann K, Ganz T, Stange EF, Bevins CL
Reduced Paneth cell {alpha}-defensins in ileal Crohn's disease
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AME 2005;102:18129-18134

2004

Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, Herrlinger KR, Stallmach A, Noack F, Fritz P, Schroder JM, Bevins CL, Fellermann K, Stange EF
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression
GUT 2004;53:1658-1664
Avril MF, Aamdal S, Grob JJ, Hauschild A, Mohr P, Bonerandi JJ, Weichenthal M, Neuber K, Bieber T, Gilde K, Guillem Porta V, Fra J, Bonneterre J, Saiag P, Kamanabrou D, Pehamberger H, Sufliarsky J, Gonzalez Larriba JL, Scherrer A, Menu Y
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study
JOURNAL OF CLINICAL ONCOLOGY 2004;22:1118-1125
Folster-Holst R, Weichenthal M, Steinsland K, Polzhofer G, Christophers E
Eczema infantum and its prognosis
ACTA DERMATO-VENEREOLOGICA 2004;84:410-412
Zeise E, Weichenthal M, Schwarz T, Kulms D
Resistance of human melanoma cells against the death ligand TRAIL is reversed by ultraviolet-B radiation via downregulation of FLIP
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2004;123:746-754
Kahle A, Weichenthal M
Purpura pigmentosa progressiva nach Einnahme von Minocyclin
Derm 2004;10:269-272
Scherer KJ, v.Stemm A, Weichenthal M
Interstitielle granulomatöse Dermatitis mit Arthritis.
Derm 2004;10:101-104

2003

Hauschild A, Weichenthal M, Balda BR, Becker JC, Wolff HH, Tilgen W, Schulte KW, Ring J, Schadendorf D, Lischner S, Burg G, Dummer
Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis.
JOURNAL OF CLINICAL ONCOLOGY  2003;21:2883-2888
Mohr P, Weichenthal M, Hauschild A
Adjuvant therapy in melanoma
ONKOLOGIE 2003;26:227-233
Wehkamp J, Harder J, Weichenthal M, Mueller O, Herrlinger KR, Fellermann K, Schroeder JM and Stange EF
Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis.
INFLAMMATORY BOWEL DISEASES 2003;9:215-223
Weichenthal M
Corynebakterien
in: A.Plettenberg/W.Meigel (Hg) Dermatologische Infektiologie. Berlin Wien; Blackwell Verlag 2003;331-338
Weichenthal M
Meningokokken-Infektion
in: A.Plettenberg/W.Meigel (Hg) Dermatologische Infektiologie. Berlin Wien; Blackwell Verlag 2003;351-354
Weichenthal M
Kodierrichtlinien Dermatologie -Version 2003- Ein Leitfaden für die klinische Praxis.
Kodierrichtlinien Dermatologie -Version 2003- Ein Leitfaden für die klinische Praxis. Münster; Schüling Verlag. 2003;

2002

Dulon, M., Weichenthal, M., Blettner, M., Breitbart, M., Hetzer, M., Greinert, R., Baumgardt-Elms, C., Breitbart, E.W.
Sun exposure and number of nevi in 5- to 6-year-old European children.
JOURNAL OF CLINICAL EPIDEMIOLOGY 2002;55:1075-1081
Foelster-Holst, R., Henseler, T., Wehde, J., Lemke, H., Weichenthal, M., Christophers, E., Hansen, H.P.
Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis.
ACTA DERMATO-VENEREOLOGICA 2002;82:245-248
Henseler T, Weichenthal M
Dermatologischer Diagnosenkatalog mit ICD-10-Schlüssel. Stationäre Versorgung - Version 2.0 (SGBV)
Verlag Hans Huber Bern-Göttingen-Toronto-Seattle 2002;

Zurück

Aktuelles:

 

Praktikum der Dermatologie

Das Hauptpraktikum Dermatologie beginnt am 17.10.2017 um 7:45 mit einer Einführungsvorlesung im Hörsaal der Hautklinik.  [mehr]

 


Dermatologie für Zahnmediziner

Die Veranstaltung beginnt am 24.10.2017  um 10:00 c.t. im Hörsaal der Hautklinik.


Lehrpreis 2017

Der Preis der Medizinischen Fakultät für die beste Lehre geht in diesem Jahr erneut an die Hautklinik  [mehr]


Neurodermitis Präventionsstudie

Studie zur frühkindlichen Anwendung von Hautpflegecremes [mehr]


Regulation von Botenstoffen der Entzündung

Kieler Team des Exzellenzclusters Entzündungsforschung deckt grundlegend neuen Mechanismus au. [mehr]


Prof. Fölster-Holst neue Präsidentin der ESPD

Professorin Dr. Regina Fölster-Holst, Klinik für Dermatologie, Venerologie und Allergologie, Medizinische Fakultät der Christian-Albrechts-Universität zu Kiel ist neue Präsidentin der Europäischen Gesellschaft für Kinderdermatologie (European Society for Pediatric Dermatology, ESPD). [mehr]


Patientenleitlinie zum Melanom erschienen

Der umfangreiche Ratgeber gibt in allgemeinverständlicher Sprache alle Empfehlungen zu Untersuchungen und Behandlungen wieder, die zuvor für die ärztliche Leitlinie zum Melanom erarbeitet worden sind.

Die Druckfassung zum kostenlosen Download [hier]   

 

Die Seite wurde zuletzt am 16.11.2017 um 11:51 geändert.